Loading…

Evidence That DDR1 Promotes Oligodendrocyte Differentiation during Development and Myelin Repair after Injury

Oligodendrocytes generate myelin sheaths vital for the formation, health, and function of the central nervous system. Mounting evidence suggests that receptor tyrosine kinases (RTKs) are crucial for oligodendrocyte differentiation and myelination in the CNS. It was recently reported that discoidin d...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2023-06, Vol.24 (12), p.10318
Main Authors: Mei, Ruyi, Qiu, Wanwan, Yang, Yingying, Xu, Siyu, Rao, Yueyu, Li, Qingxin, Luo, Yuhao, Huang, Hao, Yang, Aifen, Tao, Huaping, Qiu, Mengsheng, Zhao, Xiaofeng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Oligodendrocytes generate myelin sheaths vital for the formation, health, and function of the central nervous system. Mounting evidence suggests that receptor tyrosine kinases (RTKs) are crucial for oligodendrocyte differentiation and myelination in the CNS. It was recently reported that discoidin domain receptor 1 (Ddr1), a collagen-activated RTK, is expressed in oligodendrocyte lineage. However, its specific expression stage and functional role in oligodendrocyte development in the CNS remain to be determined. In this study, we report that is selectively upregulated in newly differentiated oligodendrocytes in the early postnatal CNS and regulates oligodendrocyte differentiation and myelination. knock-out mice of both sexes displayed compromised axonal myelination and apparent motor dysfunction. deficiency alerted the ERK pathway, but not the AKT pathway in the CNS. In addition, function is important for myelin repair after lysolecithin-induced demyelination. Taken together, the current study described, for the first time, the role of in myelin development and repair in the CNS, providing a novel molecule target for the treatment of demyelinating diseases.
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms241210318